Clinical Trial Detail

NCT ID NCT02221739
Title Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

lung non-small cell carcinoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.